PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Paroxetine hydrochloride
Presentation Product Chemical substance Chapter Items dispensed
Paroxetine 20mg tablets
0403030P0AAAAAA
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System 123,091
Paroxetine 30mg tablets
0403030P0AAABAB
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System 64,149
Paroxetine 10mg tablets
0403030P0AAAKAK
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System 45,727
Paroxetine 40mg tablets
0403030P0AAALAL
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System 15,303
Seroxat 20mg tablets
0403030P0BBAAAA
Seroxat Paroxetine hydrochloride Central Nervous System 4,745
Seroxat 30mg tablets
0403030P0BBABAB
Seroxat Paroxetine hydrochloride Central Nervous System 1,733
Seroxat 10mg tablets
0403030P0BBADAK
Seroxat Paroxetine hydrochloride Central Nervous System 1,502
Paroxetine 10mg/5ml oral suspension sugar free
0403030P0AAAGAG
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System 898
Seroxat 20mg/10ml liquid
0403030P0BBACAG
Seroxat Paroxetine hydrochloride Central Nervous System 43
Paroxetine 10mg/5ml oral liquid
0403030P0AAAFAF
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System 8
Paroxetine 20mg/5ml oral liquid
0403030P0AAADAD
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System No data available
Paroxetine 30mg/5ml oral liquid
0403030P0AAAEAE
Paroxetine hydrochloride Paroxetine hydrochloride Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.